Work packages and deliverables

WP1 provides the structural and organisational backbone of the BCLEAR project. Led by the European Association of Urology (EAU), it ensures that all scientific, operational and administrative activities are delivered in a coherent, timely and high-quality manner throughout the three-year implementation period.

This work package establishes the governance framework of the consortium, including the General Assembly, Management Board and external Advisory Boards. It oversees strategic planning, coordination between partners, financial management, risk monitoring and compliance with EU4Health grant requirements. Regular meetings, reporting cycles and communication channels support transparency, accountability and alignment across all work packages.

Quality assurance and risk management are integral to WP1. Structured monitoring of progress against milestones and deliverables allows early identification of potential delays or challenges, while mitigation measures are implemented in close collaboration with work package leaders. Continuous and periodic reporting to the European Commission ensures that progress, resource use and impact are documented in line with contractual obligations.

The main deliverables under WP1 include: 

• the Project Management Plan
• defining roles
• procedures and timelines
• the Quality Assurance and Risk Mitigation Plan
• setting out processes to safeguard scientific and operational quality
• the final Report on Action Level Indicators, which captures the project’s overall reach, outputs and measurable impact on health literacy, stakeholder engagement and behavioural change.

WP2 focuses on strengthening bladder cancer health literacy among the general public and people affected by the disease. Coordinated by the World Bladder Cancer Patient Coalition (WBCPC), this work package combines evidence generation with the co-creation of multilingual, patient-centred educational and decision-support resources.

The work begins with a comprehensive scoping review of bladder cancer health literacy across the EU, with in-depth analysis of gaps, barriers and good practices, and particular attention to Greece, Poland and Hungary. This evidence base informs the design of all subsequent materials and ensures that interventions respond to real-world needs and inequalities.

Based on these findings, WP2 develops a multi-modal educational toolbox covering prevention, early diagnosis, treatment, rehabilitation and survivorship for both non-muscle-invasive and muscle-invasive bladder cancer. Resources are produced in accessible formats, including videos, infographics, booklets and online modules, and in four languages (English, Polish, Greek and Hungarian). The toolbox is designed to support different levels of health literacy and learning preferences.

A central component of WP2 is the development of interactive shared decision-making tools, enabling patients to better understand treatment options, risks and benefits, and to participate actively in decisions about their care. Internal assessment versions are first produced for quality review and piloting, followed by validated public versions for EU-wide dissemination.

Key deliverables include:

• the bladder cancer health literacy scoping review
• the internal and public versions of the citizen educational toolbox
• the internal and public releases of the shared decision-making modules.

WP3 addresses the needs of healthcare professionals, equipping them with knowledge, skills and tools to support shared decision-making and patient-centred bladder cancer care. Led by EAU, it complements the citizen toolbox by strengthening clinical practice and communication.

This work package develops evidence-based guidance on bladder cancer prevention, early detection, treatment options and patient care, integrating the latest scientific knowledge with practical recommendations. It also focuses on the effective use of shared decision-making tools in routine practice, helping clinicians to align clinical choices with patients’ values, preferences and life circumstances.

A further emphasis is placed on communication and psychosocial support. Training materials address how to discuss diagnosis, treatment and prognosis, and how to recognise and respond to the emotional and psychological impact of bladder cancer on patients and their families.

Deliverables under WP3 include:

• a step-by-step guide for implementing shared decision-making in clinical settings
• good practice guidelines covering prevention
• treatment and care pathways
• a multilingual training module designed for urologists, general practitioners and other healthcare professionals involved in bladder cancer care.

WP4 ensures the scientific quality, usability and reliability of all educational and decision-support materials developed within the project. Led by Erasmus University Medical Center (EMC), it applies standardised evaluation frameworks to both patient-facing and healthcare professional-facing resources.

Educational materials are assessed using validated instruments such as the Patient Education Materials Assessment Tool (PEMAT), which examines clarity, understandability and actionability. Shared decision-making tools are evaluated against the International Patient Decision Aid Standards (IPDAS), ensuring they meet international benchmarks for evidence-based, patient-centred decision support.

Knowledge assessment tools, including multiple-choice and true/false questionnaires, are used to evaluate learning outcomes for healthcare professional-focused materials. Findings from all assessments are fed back into content refinement, strengthening quality, accessibility and clinical relevance.

Deliverables include: 

• detailed assessment reports for patient education materials
• decision aids and professional training resources
• providing structured evidence to support final validation and dissemination.

WP5 translates project outputs into real-world impact through strategic communication, outreach and stakeholder engagement. Coordinated by WBCPC, it aims to raise public and professional awareness of bladder cancer, promote health literacy and ensure wide uptake of BCLEAR tools and recommendations.

A stakeholder-tailored dissemination strategy guides communication activities at EU and national levels. This includes digital platforms, social media, printed materials, awareness campaigns, professional meetings and policy-focused events. Special attention is given to countries participating in pilot activities, while also supporting broader EU-wide visibility.

Key dissemination tools include the BCLEAR project website, informational leaflets, and regular updates on milestones, events and results. Awareness activities are aligned with existing initiatives such as Bladder Cancer Awareness Month, and include stakeholder workshops, scientific sessions and policy dialogue.

Deliverables comprise: 

• the project sub-website
• communication materials
• the dissemination strategy
• the final dissemination report documenting reach, engagement and lessons learned.

WP6 ensures that the benefits of BCLEAR extend beyond the project’s funding period. Led by EAU, it focuses on embedding validated tools, methods and good practices into sustainable structures and making them transferable across Europe.

Central to this work package is the development of a general good practice guide and a virtual library hosting educational materials, decision aids, templates and implementation guidance. These resources are designed to support adaptation, translation and reuse by healthcare providers, patient organisations and policymakers in other Member States.

WP6 also establishes an evaluation framework to assess overall project outcomes, document impact, and generate recommendations for future scale-up and policy integration. Stakeholder engagement activities support uptake of the tools and encourage their incorporation into national cancer plans, professional training and health literacy strategies.

Key deliverables include:

• the BCLEAR good practice guide
• the virtual resource library
• the final evaluation report outlining impact, sustainability and pathways for long-term use.